PTK2 and cancer: This includes changes in invasive membrane structures (blebbing, lamellipodia) and genes related to cancer stemness (Notch1, Oct3), inflammation (NK-κB, TNF, IL8), and cell-cell and cell-matrix adhesion (integrin, MAPK, LINC, FAK, etc.).